SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018299
Filing Date
2019-05-10
Accepted
2019-05-10 08:31:15
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mack-10q_20190331.htm 10-Q 1524057
2 EX-31.1 mack-ex311_6.htm EX-31.1 9557
3 EX-31.2 mack-ex312_7.htm EX-31.2 9508
4 EX-32.1 mack-ex321_8.htm EX-32.1 5729
5 EX-32.2 mack-ex322_9.htm EX-32.2 5665
  Complete submission text file 0001564590-19-018299.txt   5258737

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mack-20190331.xml EX-101.INS 1152725
7 XBRL TAXONOMY EXTENSION SCHEMA mack-20190331.xsd EX-101.SCH 39706
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20190331_cal.xml EX-101.CAL 42749
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20190331_def.xml EX-101.DEF 115488
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20190331_lab.xml EX-101.LAB 285467
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20190331_pre.xml EX-101.PRE 223286
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 19812948
SIC: 2834 Pharmaceutical Preparations